Dr. Ilyas Ikramuddin, D.O

NPI: 1457352940
Total Payments
$4,175
2024 Payments
$1,464
Companies
32
Transactions
232
Medicare Patients
2,460
Medicare Billing
$268,843

Payment Breakdown by Category

Food & Beverage$4,042 (96.8%)
Other$133.25 (3.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,042 231 96.8%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $133.25 1 3.2%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $948.61 63 $0 (2024)
E.R. Squibb & Sons, L.L.C. $468.68 4 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $383.63 25 $0 (2024)
Celgene Corporation $379.55 30 $0 (2024)
Janssen Biotech, Inc. $255.17 13 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $224.32 20 $0 (2024)
GENZYME CORPORATION $178.08 9 $0 (2024)
Madrigal Pharmaceuticals $165.91 2 $0 (2024)
INTERCEPT PHARMACEUTICALS, INC. $152.22 3 $0 (2023)
Phathom Pharmaceuticals, Inc. $136.49 10 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,464 75 ABBVIE INC. ($350.77)
2023 $1,274 58 ABBVIE INC. ($301.29)
2022 $64.01 3 Janssen Biotech, Inc. ($48.14)
2021 $32.74 2 AbbVie Inc. ($32.74)
2020 $196.29 12 AbbVie Inc. ($62.54)
2019 $552.03 43 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($129.63)
2018 $384.59 22 FUJIFILM Medical Systems USA, Inc. ($133.25)
2017 $207.33 17 AbbVie, Inc. ($65.09)

All Payment Transactions

232 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.51 General
Category: Gastroenterology
12/23/2024 Organon Llc RENFLEXIS (Drug), HADLIMA Food and Beverage In-kind items and services $12.30 General
Category: INFLIXIMAB
12/10/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $7.86 General
Category: IMMUNOLOGY
12/05/2024 Organon Llc HADLIMA (Drug), RENFLEXIS Food and Beverage In-kind items and services $14.65 General
Category: ADALIMUMAB-BWWD
12/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $23.50 General
Category: Gastroenterology
11/26/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $1.23 General
Category: GASTROENTEROLOGY
11/26/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $1.12 General
Category: GASTROENTEROLOGY
11/26/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $1.04 General
Category: GASTROENTEROLOGY
11/26/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $0.44 General
Category: GASTROENTEROLOGY
11/19/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $12.97 General
Category: IMMUNOLOGY
11/18/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $21.60 General
Category: GASTROENTEROLOGY
11/11/2024 Madrigal Pharmaceuticals REZDIFFRA (Drug) Food and Beverage In-kind items and services $144.48 General
Category: LIVER DISEASE
11/05/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $1.87 General
Category: ENDOCRINOLOGY
11/05/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $1.14 General
Category: ENDOCRINOLOGY
11/04/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $21.43 General
Category: LIVER DISEASE
10/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.92 General
Category: Gastroenterology
10/17/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $1.22 General
Category: GASTROENTEROLOGY
10/16/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $1.59 General
Category: GASTROENTEROLOGY
10/15/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $16.32 General
Category: Neuroscience
10/14/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $21.80 General
Category: IMMUNOLOGY
10/14/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $14.29 General
Category: IMMUNOLOGY
10/11/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $20.57 General
Category: GASTROENTEROLOGY
10/01/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $19.72 General
Category: Neuroscience
09/30/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $21.84 General
Category: GASTROENTEROLOGY
09/27/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $22.62 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 631 677 $372,922 $73,112
2022 10 530 588 $265,562 $58,574
2021 14 677 764 $309,529 $78,232
2020 14 622 694 $291,646 $58,924
Total Patients
2,460
Total Services
2,723
Medicare Billing
$268,843
Procedure Codes
50

All Medicare Procedures & Services

50 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 95 97 $110,386 $19,371 17.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 146 176 $44,000 $15,917 36.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 120 120 $39,360 $13,028 33.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 46 47 $16,638 $6,500 39.1%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 47 48 $26,208 $4,101 15.6%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 40 51 $13,806 $3,100 22.5%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 29 30 $14,052 $2,666 19.0%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 29 29 $56,289 $2,297 4.1%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 11 11 $8,052 $1,979 24.6%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 23 23 $25,471 $1,806 7.1%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 11 11 $8,052 $1,280 15.9%
43450 Dilation of esophagus Facility 2023 34 34 $10,608 $1,068 10.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 138 183 $37,252 $16,141 43.3%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 71 71 $80,798 $12,912 16.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 104 104 $32,112 $11,683 36.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 42 44 $12,720 $5,775 45.4%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 48 49 $23,712 $3,675 15.5%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 41 41 $46,330 $3,251 7.0%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 24 24 $17,864 $1,835 10.3%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 22 32 $6,710 $1,790 26.7%
43450 Dilation of esophagus Facility 2022 28 28 $6,228 $843.10 13.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 12 12 $1,836 $668.00 36.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 183 248 $47,455 $22,272 46.9%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 79 80 $91,040 $15,174 16.7%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 99 99 $30,056 $11,253 37.4%

About Dr. Ilyas Ikramuddin, D.O

Dr. Ilyas Ikramuddin, D.O is a Gastroenterology healthcare provider based in Beavercreek, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457352940.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ilyas Ikramuddin, D.O has received a total of $4,175 in payments from pharmaceutical and medical device companies, with $1,464 received in 2024. These payments were reported across 232 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,042).

As a Medicare-enrolled provider, Ikramuddin has provided services to 2,460 Medicare beneficiaries, totaling 2,723 services with total Medicare billing of $268,843. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Beavercreek, OH
  • Active Since 08/09/2005
  • Last Updated 08/24/2020
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1457352940

Products in Payments

  • ZEPOSIA (Drug) $742.82
  • RINVOQ (Biological) $293.25
  • XIFAXAN (Drug) $235.42
  • CREON (Drug) $219.48
  • DUPIXENT (Biological) $209.98
  • OCALIVA (Drug) $152.22
  • REZDIFFRA (Drug) $144.48
  • VOQUEZNA (Drug) $136.49
  • ESD - Core Endoscopy (Device) $133.25
  • STELARA (Biological) $121.60
  • REMICADE (Biological) $110.95
  • SKYRIZI (Biological) $98.43
  • XELJANZ (Drug) $93.11
  • Amitiza (Drug) $85.41
  • TRULANCE (Drug) $82.21
  • Entyvio (Biological) $81.69
  • Humira (Biological) $79.25
  • VIBERZI (Drug) $76.56
  • Mavyret (Drug) $69.92
  • Creon (Drug) $52.10

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Beavercreek